The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population

Journal of the American College of Cardiology

Volumn 32, Issue 6, 1998, Pages 1709-1716

  Jääskeläinen, Pertti ^a   Soranta, Marja ^b   Miettinen, Raija ^a   Saarinen, Laura ^a   Pihlajamäki, Jussi ^a   Silvennoinen, Karoliina ^a   Tikanoja, Tero ^a   Laakso, Markku ^a   Kuusisto, Johanna ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; DNA; MYOSIN HEAVY CHAIN; SERINE; TROPOMYOSIN; TRYPTOPHAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; FEMALE; FINLAND; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FINLAND; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MUTATION, MISSENSE; MYOCARDIUM; MYOSIN HEAVY CHAINS; PEDIGREE; TROPOMYOSIN; VARIATION (GENETICS);

EID: 0344878860     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00448-3     Document Type: Article

References (36)

1. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy I. N Engl J Med 1987;316:780-9.
2. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy II. N Engl J Med 1987;316:844-52.
3. Watkins H, Thierfelder L, Hwang DS, McKenna W, Seidman JG, Seidman CE. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 1992;90:1666-71.
4. Geisterfer Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta-cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
5. Marian AJ, Yu QT, Mares A Jr, Hill R, Roberts R, Perryman MB. Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest 1992;90:2156-65.
6. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.
7. Thierfelder L, Watkins H, MacRae C, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-12.
8. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-64.
9. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi Takihara K. Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1995;27:2053-8.
10. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995;11:434-7.
11. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11:438-40.
12. Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996;13:63-69.
13. Kimura A, Harada H, Park JE, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997;16:379-82.
14. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92:1336-47.
15. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H, et al. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene. Heart 1996;76:63-5.
16. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
17. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320:749-55.
18. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 1993;30:857-65.
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
20. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997;77: 130-2.
21. Huwez FU, Houston AB, Watson J, McLaughlin S, Macfarlane PW. Age and body surface area related normal upper and lower limits of M mode echocardiographic measurements and left ventricular volume and mass from infancy to early adulthood. Br Heart J 1994;72:276-80.
22. Jaenicke T, Diederich KW, Haas W, et al. The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics 1990;8:194-206.
23. Liew CC, Sole MJ, Yamauchi-Takihara K, et al. Complete sequence and organization of the human cardiac beta-myosin heavy chain gene. Nucleic Acids Res 1990;18:3647-51.
24. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86:2766-70.
25. Kretz KA, Carson GS, O'Brien JS. Direct sequencing from low-melt agarose with Sequenase. Nucleic Acids Res 1989;17:5864.
26. Schwartz K, Beckmann J, Dufour C, et al. Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families. Circ Res 1992;71:3-8.
27. Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 1984;36:460-5.
28. Ott J. Analysis of Human Genetic Linkage. 2nd ed. Baltimore: The Johns Hopkins University Press, 1992.
29. Peltonen L, Pekkarinen P, Aaltonen J. Messages from an isolate: lessons from the Finnish gene pool. Biol Chem Hoppe Seyler 1995;376:697-704.
30. Machida M. Genetic heterogeneity of hypertrophic cardiomyopathy in Japanese. Hokkaido Igaku Zasshi 1994;69:1024-34.
31. Coviello DA, Maron BJ, Spirito P, et al. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol 1997;29:635-40.
32. Reina M, Brunzell JD, Deeb SS. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res 1992;33:1823-32.
33. Nevin DN, Brunzell JD, Deeb SS. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 1994;14:869-73.
34. Winderickx J, Lindsey DT, Sanocki E, Teller DY, Motulsky AG, Deeb SS. Polymorphism in red photopigment underlies variation in colour matching. Nature 1992;356:431-3.
35. Winderickx J, Battisti L, Motulsky AG, Deeb SS. Selective expression of human X chromosome-linked green opsin genes. Proc Natl Acad Sci USA 1992;89:9710-4.
36. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb SS. Insulin receptor substrate 1 variants in non-insulin-dependent diabetes. J Clin Invest 1994; 94:1141-6.